/
Markets
Crypto
News
Forecasts
Forex Brokers
Calendars
Macro Data
About us
Commodity Prices
Currency Rates
Cryptocurrency Prices
Global Market Indices
Stock Prices
ETF Prices
Cryptocurrency Prices
Crypto Exchanges
Crypto Wallets
Cryptocurrency News
Cryptocurrency Forecasts
Commodity News
Forex News
Crypto News
Stock Market News
Economic News
Opinions
Broker News
Commodities
Forex
Crypto
Indices
Natural Gas Forecasts
Gold Forecasts
WTI Crude Oil Forecasts
S&P 500 Forecasts
Forex Brokers Reviews
Best Brokers Guides
Compare Forex Brokers
Best Forex Brokers
Best Forex Platforms
Best MT4 Brokers
Best for Trading Gold
Best Brokers in Australia
Best Brokers for Beginners
Best Brokers in UK
Brokers Promotions
Stock Brokers
Economic Calendar
Earnings Calendar
Splits Calendar
Dividends Calendar
Holiday Calendar
IPO Calendar
Stock Screener
Currency Converter
Global Macro indicators
Sovereign Credit Ratings
Global Major Indicators
Interest Rates
United States Indicators
China Indicators
Australia Indicators
Euro Area Indicators
About us
Contact Us
Terms Of Use
Become A Contributer
EUR/USD
+0.21%
Natural Gas
+2.80%
Gold
N/A
BTC
N/A
ETH
N/A
SPX
+1.02%
VIX
N/A
Economic Calendar
EUR/USD
+0.21%
Natural Gas
+2.80%
Gold
N/A
BTC
N/A
ETH
N/A
SPX
+1.02%
VIX
N/A
Economic Calendar
BTC
N/A
ETH
N/A
XRP
N/A
ADA
N/A
SOL
N/A
Review
Review
Review
Eurozone Economic Sentiment Indicator Falls to 95.6 in April
29 minutes ago
Bitcoin ETFs: After Record $328M Outflows, What Happens Next?
about 16 hours ago
Vitalik Buterin Backs Ethereum PoS Transition amid Community Debates
about 17 hours ago
Crypto Market Outlook: BTC, SOL, ETH, DOGE Face Downward Pressure
about 18 hours ago
Crypto Market Recap: Ripple (XRP), SHIB and Binance Seize the Limelight
1 day ago
The Week Ahead: US Jobs Report, the Fed, China Stats, and Yen Intervention Chatter
1 day ago
Crypto Market Retreats Due to Overhang of Sellers
about 1 hour ago
EUR/USD, GBP/USD, DXY Price Forecast: DXY Gains Support at $105.52; Buy Now?
about 2 hours ago
Silver (XAG) Daily Forecast: Resilient at $27.27; US Dollar Weakness Boosts Prices
about 2 hours ago
Gold (XAU) Daily Forecast: Steady at $1,234; Potential Uptrend Ahead?
about 3 hours ago
Natural Gas and Oil Forecast: Adjustments Amid 2.7% US Inflation; Time to Buy?
about 4 hours ago
DAX Index Today: German Inflation and ECB Rate Cut Speculation
about 7 hours ago
Quick Links
:
Forecasts
Economic Calendar
Commodities
Trade Now
ad
ad
Advertisement
Advertisement
home
stocks
COCP
profile
Cocrystal Pharma Inc
Follow
COCP
(
Nasdaq - US
)
N/A
1.55
+0.04 (+2.65%)
in
:
usd
•
As of: Apr 26, 2024 15:40
UTC -4
Open
1.55
High
1.55
Low
1.55
Overview
Profile
Financials
Advanced Chart
History
Earnings
About
Cocrystal Pharma Inc
CEO
Sam Lee
Headquarters
19805 n. creek parkway
bothell, wa 98011, united states
Auditor
Weinberg & Company, P.A
Employees
12
Share Holders
434
Website
www.cocrystalpharma.com
Industry
pharmaceuticals major
Sector
health technology
Company Overview
Cocrystal Pharma, Inc. is a clinical stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of hepatitis viruses, influenza viruses, and noroviruses. Cocrystal employs unique structure-based technologies and Nobel Prize winning expertise to create first- and best-in-class antiviral drugs. CC-31244 is a Phase 2a ready broad-spectrum novel non-nucleoside replication inhibitor of HepC. Phase 1b studies in HepC infected patients showed the largest reduction in viral load of any non-nucleoside inhibitor tested to date. The next step for CC-31244 is clinical trials as part of a cocktail for ultra-short therapy of 2 to 6 weeks. The lead candidate for influenza has advanced to IND-enabling studies. It is effective in animal models against both the pandemic and seasonal strains of influenza. In addition, the Company has a pipeline of promising early preclinical programs. Two private investors own approximately 48% of the Company.
Cocrystal Pharma Inc
Statistics
Valuation Measures
Market Capitalization
2
15.76M
Enterprise Value
-10.66M
Enterprise Value/EBITDA
(ttm)
0.53
Price to Earnings Ratio
(ttm)
N/A
Price to Book
(mrq)
0.60
Price to Sales
(ttm)
N/A
Price to Cash
(ytd)
N/A
Profitability
Gross Margin
(ttm)
0.00%
Operating Margin
(ttm)
N/A
Profit Margin
(ttm)
0.00%
Return on Equity
(ttm)
-59.62%
Return on Invested Capital
(ttm)
-57.47%
Return on Assets
(ttm)
-54.62%
Income Statement
Revenue
(ttm)
0.00
Revenue Per Share
(ttm)
0.00
Gross Profit
(ttm)
0.00
EBITDA
(ttm)
3
-19.95M
Net Income Avi to Common
(ttm)
-17.98M
Diluted EPS
(ttm)
-1.99
Share Statistics
Beta (5Y Monthly)
1.34
52-Week Change
-35.95%
S&P500 52-Week Change
25.74%
S&P500 Member
No
Stock Optionable
No
Total Shares Outstanding
1
10.17M
Dividend Yield
0.00%
Float
4
7.62M
%
Held by Insiders
25.06%
%
Held by Institutions
6.72%
Balance Sheet
Total Cash
(mrq)
26.43M
Total Cash Per Share
(mrq)
2.60
Total Debt
(mrq)
0.00
Total Debt/Equity
(mrq)
0.00%
Current Ratio
(mrq)
8.92%
Quick Ratio
(mrq)
8.92%
Book Value Per Share
(mrq)
2.59
Cash Flow
Operating Cash Flow Per Share
(ytd)
-1.52
Free Cash Flow
(ytd)
-14.78M
Table Key
mrq
=
Most Recent Quarter
ttm
=
Trailing Twelve Months
ytd
=
Year To Date
Footnotes
Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.
1
Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2
Market Cap is calculated using total shares outstanding and the most recent share price.
3
EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4
The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Sponsored
Sponsored
This Section / Page contains links to the 3rd party websites of our top partners from whom we may receive compensation.
Trade With A Regulated Broker